Vir Biotechnology Inc

NASDAQ: VIR
$9.60
-$0.17 (-1.7%)
Closing Price on November 8, 2024

VIR Stock Chart and Intraday Price

VIR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 1,517.76M USD
Shares Outstanding 135,032,000
Vir Biotechnology Inc is a pioneering immunology company focused on developing treatments for serious infectious diseases. With a robust pipeline, it targets conditions like chronic hepatitis, HIV, respiratory viruses, influenza, HPV lesions, and COVID-19. The company collaborates with notable organizations and companies, including the Bill & Melinda Gates Foundation, National Institutes of Health, and GlaxoSmithKline, to advance its research and development efforts. Founded in 2016 and based in San Francisco, Vir Biotechnology leverages partnerships and cutting-edge science to create solutions for global health challenges.

VIR Articles

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Tuesday's top analyst upgrades and downgrades included Altria, Apple, D.R. Horton, Equitrans Midstream, Fortinet, General Electric, Nextracker, Palo Alto Networks, Pfizer, Silvergate Capital, Tesla...
Tuesday’s top analyst upgrades and downgrades included Bilibili, Carvana, Crocs, GameStop, Goldman Sachs, Nike, Sarepta Therapeutics, Vir Biotechnology and Weber.
Monday’s top analyst upgrades and downgrades included Bionano Genomics, CarMax, CNH Industrial, Global Payments, Infosys, Huya, JD.com, Oshkosh, Restaurant Brands International and WiPro.
Monday's top analyst upgrades and downgrades included Carnival, Five9, Knight-Swift, Las Vegas Sands, Norwegian Cruise Line, Paysafe, Warby Parker and Whirlpool.
Thursday's top analyst upgrades and downgrades included ADT, Chevron, Camping World, Costco, D.R. Horton, General Electric, Nio and Occidental Petroleum.
Wednesday's top analyst upgrades and downgrades included Applied Materials, Caterpillar, Costco Wholesale, JPMorgan, Spotify, Vertex Pharmaceutical, Vornado Realty Trust and Whiting Petroleum.
Wednesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Amazon.com, Diageo, eBay, Etsy, Home Depot, MGIC Investment, Netflix, Sirius XM and Vir Biotechnology.
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Friday's top analyst calls included Amazon, Adobe, AMD, Apple, BlackRock, Broadcom, Caterpillar, Deere, Microsoft, Morgan Stanley, Oracle and Slack.